Name: Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (en Inglés)
Price: 497.39 PEN
Availability: InStock
Author: Hays, Priya
ISBN: 9783030963781

portada Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Hays, Priya

Idioma

Inglés

N° páginas

315

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 1.8 cm

Peso

0.47 kg.

ISBN13

9783030963781

N° edición

Categorías

Oncología
Hematología
Genética (no médica)

Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (en Inglés)

Hays, Priya (Autor) · Springer · Tapa Blanda

Libro Nuevo

S/ 497,39

S/ 994,77

Ahorras: S/ 497,39

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 31 de Julio y el Miércoles 14 de Agosto.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (en Inglés)"

This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes both solid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies.